comScore
Active Stocks
Fri Dec 01 2023 14:32:10
  1. Tata Steel share price
  2. 129.85 1.48%
  1. Reliance Industries share price
  2. 2,387.2 0.45%
  1. NTPC share price
  2. 270.65 3.58%
  1. ICICI Bank share price
  2. 950 1.58%
  1. HDFC Bank share price
  2. 1,555.65 -0.21%
Business News/ Science / Health/  Covid-19: Aspirin doesn’t help patients survive in large, says UK study
Back Back

Covid-19: Aspirin doesn’t help patients survive in large, says UK study

Doctors were hopeful that aspirin could help combat the blood clots Covid-19 can cause in the lungs and elsewhere, but the trial results suggest the medicine will instead join the long list of treatments that can’t be repurposed to combat the coronavirus

The trial is part of a wider program called Recovery meant to test a range of existing drugs for effectiveness against Covid (Photo: AP)Premium
The trial is part of a wider program called Recovery meant to test a range of existing drugs for effectiveness against Covid (Photo: AP)

Aspirin doesn’t improve chances of survival for patients hospitalized with Covid-19, according to a large study.

The 120-year-old drug, which is widely used to thin the blood of heart-disease patients, made no difference in mortality after about a month in a clinical trial that involved almost 15,000 volunteers. Survivors did spend one less day in the hospital compared with those who didn’t get a daily dose of aspirin, the researchers found.

Doctors were hopeful that aspirin could help combat the blood clots Covid-19 can cause in the lungs and elsewhere, but the trial results suggest the medicine will instead join the long list of treatments that can’t be repurposed to combat the coronavirus. Other letdowns include the malaria medicine hydroxychloroquine and the HIV medications ritonavir and lopinavir.

“Aspirin is inexpensive and widely used in other diseases to reduce the risk of blood clots, so it is disappointing that it did not have a major impact," said Martin Landray, a professor of medicine and epidemiology at the University of Oxford and one of the study’s lead authors.

The trial is part of a wider program called Recovery meant to test a range of existing drugs for effectiveness against Covid. The findings have yet to be peer-reviewed and published in a medical journal. Recovery helped show that at least one other treatment, Roche Holding AG’s arthritis drug Actemra, could boost patients’ survival.

Milestone Alert!
Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Updated: 08 Jun 2021, 07:02 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App